Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hutchinson's Melanotic Freckle × Imiquimod × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 28 Carcinoma, Basal Cell 12 Melanoma 7 Keratosis 3 Skin Neoplasms 1 Precancerous Conditions 1 Lymphoma, T-Cell, Cutaneous 1 Leukoplakia 1 Leukokeratosis, Hereditary Mucosal 1 Hutchinson's Melanotic Freckle 1 Facies 1 Carcinoma, Squamous Cell 1

Interventions

Intravital Microscopy 1 Imiquimod 1 Equipment and Supplies 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01088737 2019-08-13

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Medical University of Graz

Phase 2/3 Unknown

Melanoma, Hutchinson's Melanotic Freckle

Data powered by HemOnc (CC BY 4.0) Colophon ⚡